Transarterial Ethylene Vinyl Alcohol Copolymer Visualization and Penetration After Embolization of Life-Threatening Hemoptysis: Technical and Clinical Outcomes

Journal Article · Fri Jun 15 04:00:00 EDT 2012 · Cardiovascular and Interventional Radiology

DOI:https://doi.org/10.1007/S00270-011-0270-3· OSTI ID:21608511

Bommart, Sebastien ^[1]; Bourdin, Arnaud ^[2]; Giroux, Marie France ^[3]; Klein, Francois; Micheau, Antoine; Bares, Valerie Monnin; Kovacsik, Helene ^[1]

---

1. CHU of Montpellier, Arnaud de Villeneuve Hospital, Department of Radiology (France)
2. CHU of Montpellier, Arnaud de Villeneuve Hospital, Department of Respiratory Diseases (France)
3. Centre Hospitalier de l'Universite de Montreal, Notre-Dame Hospital, Department of Radiology (Canada)

Objectives: This study was designed to evaluate the feasibility of using ethylene vinyl alcohol copolymer (EVAC) for bronchial artery embolization (BAE) in patients with life-threatening hemoptysis and to compare the visualization and transarterial penetration of EVAC under fluoroscopy and computed tomography (CT). Methods: Fifteen patients (mean age, 62.9 (range, 24-82) years) who were referred for life-threatening hemoptysis (27 month period) underwent BAE using EVAC. All patients had thoracic CT examination before and after BAE. Technical and clinical results were evaluated. Visibility and extent of cast penetration (graded 1-4) on fluoroscopy and postprocedure CT were assessed and compared. Results: BAE was feasible in all but one artery (due to spasm; n = 27; 96.4%). No procedure-related complications or deaths were detected. Two patients had recurrent bleeding in the following day (13.3%). Immediate clinical success was achieved in 14 cases (93.3%) after reembolization of pulmonary artery pseudoaneurysm in one patient (mean follow-up, 43.5 (range, 14-148) days). Visibility of the cast was possible in 73.3% of patients (n = 11) under fluoroscopy (mean cast penetration 1.66) and in all patients under CT (mean cast penetration 2.06). The postinjection fluoroscopic visibility in 6 of 15 (40%) patients was inferior to CT (P < 0.02). Conclusions: BAE with EVAC seems to be feasible and safe with immediate control of hemoptysis in most patients. The postinjection fluoroscopic visibility of EVAC under fluoroscopy was inferior to CT.

• OSTI ID: 21608511
• Journal Information: Cardiovascular and Interventional Radiology, Journal Name: Cardiovascular and Interventional Radiology Journal Issue: 3 Vol. 35; ISSN 0174-1551; ISSN CAIRDG
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
ARTERIES
BIOMEDICAL RADIOGRAPHY
BLOOD VESSELS
BODY
CARDIOVASCULAR SYSTEM
COMPUTERIZED TOMOGRAPHY
CONTROL
COPOLYMERS
DIAGNOSTIC TECHNIQUES
FLUOROSCOPY
MEDICINE
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC POLYMERS
ORGANS
PATIENTS
POLYMERS
RADIOLOGY
TOMOGRAPHY